These reports confirm compound identity and purity, giving you direct access to the same data we use for internal quality verification.
Muscle preservation: Because AOD 9604 targets adipose tissue specifically and does not suppress systemic anabolic signaling, researchers have hypothesized that it may allow for fat loss with less collateral impact on lean mass, though this has not been formally tested in head-to-head trials
Patients report experiencing results almost immediately
GIP (glucose-dependent insulinotropic polypeptide) further enhances insulin sensitivity and may directly influence fat metabolism in adipose tissue
J., Luo, Z., Volinia, S., Rassenti, L
Historical Clinical Trials (1980s) The most direct evidence for DSIP as a sleep therapeutic comes from a series of clinical trials conducted in the late 1970s and early 1980s